Blue Medical Investments

Blue Medical is a Dutch medical technology company specializing in the development and manufacture of innovative interventional cardiology and vascular devices. The company is a pioneer in drug-eluting balloon (DEB) technology, notably with its Pioneer product line which utilizes a proprietary coating for the controlled release of paclitaxel to treat arterial stenosis. In addition to its drug-eluting platforms, Blue Medical offers a comprehensive portfolio of high-performance PTCA catheters and stent delivery systems. Founded in 1998 and headquartered in Helmond, the company has established a significant global footprint in the vascular intervention market. In 2016, Blue Medical was acquired by Wellinq, a Dutch medical device group, which integrated Blue Medical's R&D and manufacturing expertise into its broader cardiovascular and peripheral vascular offerings.